CRISPR Therapeutics AG (CRSP)

40.72 +0.34 (+0.83%) USD  |  NASDAQ  |  Dec 20, 16:00
40.87 +0.15 (+0.37%) After-Hours: 20:00
More

CRISPR Therapeutics Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for CRSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Vertex Pharmaceuticals Inc Upgrade
Lonza Group Ltd Upgrade
AC Immune SA Upgrade
Addex Therapeutics Ltd Upgrade
NLS Pharmaceutics Ltd --